Literature DB >> 2970407

Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.

R Frydman1, J Belaisch-Allart, I Parneix, R Forman, A Hazout, J Testart.   

Abstract

Luteinizing hormone-releasing hormone (LH-RH) agonists are being increasingly used in ovulation stimulation protocols in IVF programs. The results of two methods of utilization of LH-RH agonists are compared. In the long protocol, gonadotropin stimulation was commenced only after a preliminary period of pituitary desensitization with LH-RH agonist. In the short protocol, exogenous gonadotropins were administered shortly after the start of LH-RH agonist therapy, benefiting from the gonadotropin flare up effect. One hundred eighty-six patients were equally divided between the two treatments. There was no difference in the ovarian response on the day of human chorionic gonadotropin (hCG) or the number of mature oocytes recovered. The cleavage rate of mature oocytes was higher in the short protocol (70% versus 56% P less than 0.01). The ongoing pregnancy rate per treatment cycle was similar in both groups (18% in the long protocol and 16% in the short protocol). Analysis of the luteal phases revealed a trend for higher progesterone values in the long protocol although this was only significant on the 2nd day following oocyte retrieval. As the clinical results were similar, other factors should be taken into account when deciding therapy. These include patient convenience, cost, and side effects. Other schedules of ovulation stimulation with LH-RH agonists are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970407     DOI: 10.1016/s0015-0282(16)60135-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Ovarian suppression with leuprolide acetate: comparison of luteal, follicular, and flare-up administration in controlled ovarian hyperstimulation for oocyte retrieval.

Authors:  P R Gindoff; J L Hall; R J Stillman
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-04

2.  Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.

Authors:  A B van de-Helder; F M Helmerhorst; A Blankhart; R Brand; C Waegemaekers; N Naaktgeboren
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

3.  The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).

Authors:  J H Segars; G A Hill; S H Bryan; C M Herbert; K G Osteen; B J Rogers; A C Wentz
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

4.  Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.

Authors:  Selmo Geber; Liana Sales; Marcos A C Sampaio
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

5.  Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.

Authors:  I Henig; P J Chan; S G Prough; D R Tredway
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-08

6.  A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response.

Authors:  M Dirnfeld; Y Gonen; A Lissak; S Goldman; M Koifman; Y Sorokin; H Abramovici
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

7.  Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.

Authors:  I Wada; P L Matson; S A Troup; B A Lieberman
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

8.  The effects of GnRH analogs on serum and follicular fluid leptin levels and pregnancy outcomes in short protocols of assisted reproductive technology.

Authors:  Mete Ahmet Ergenoğlu; Ahmet Özgür Yeniel; Ayşin Akdoğan; Ege Nazan Tavmergen Göker; Erol Tavmergen
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

9.  Low dose gonadotropin-releasing hormone agonist treatments with early discontinuation for controlled ovarian hyperstimulation in an in vitro fertilization program.

Authors:  Su-Long Lee; Jinu-Hwang Su; Katsuo Ikuta; Kaoru Suzumori
Journal:  Reprod Med Biol       Date:  2003-03-25

Review 10.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.